ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Do Protocol Biopsies in the Highly Sensitized Improve Renal Allograft Survival? A Single Center Evaluation of 2 Year Graft Function

    S. Kuppachi, R. Kalil, M. Fraer, M. Sanders, M. Swee, Z. Stewart, C. Thomas.

    Organ Transplant Center, University of Iowa, Iowa City, IA.

    Highly sensitized kidney transplant recipients (hsKTR) are at an increased risk of antibody mediated rejection (AMR). Following implementation of the new kidney allocation system (KAS)…
  • 2018 American Transplant Congress

    B-Cell Depletion with Rituximab Exacerbates Anti-Donor CD4+ T-Cell Responses in Patients with Donor-Specific Anti-Human Leukocyte Antigen Antibodies

    A. Tanaka, K. Ide, Y. Tanaka, M. Ohira, H. Tahara, S. Shimizu, H. Ohdan.

    Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan.

    Background: It has been reported that preformed donor-specific anti-human leukocyte antigen antibodies (DSAs) were associated with poor graft outcomes in kidney transplant recipients. To eliminate…
  • 2018 American Transplant Congress

    Integration of Blood Type Incompatibility Desensitization Protocols into Kidney Paired Donation (KPD) Programs

    F. Karami,1 M. Nayebpour,2 M. Gentili,1 N. Koizumi,2 K. Melancon.3

    1Industrial Engineering, University of Louisville, Louisville, KY; 2Schar School of Policy and Government, George Mason University, Arlington, VA; 3Department of Surgery, George Washington University Hospital, Washington DC.

    Even if blood type incompatibility (ABOi) is one of the most significant barriers in transplantation, recent studies report that the outcomes of ABOi transplants with…
  • 2018 American Transplant Congress

    Evaluation of Allergy to Tacrolimus in Kidney Transplant Candidates and Recipients with a History of Macrolide Antibiotic Allergy

    J. Trofe-Clark,1,2 M. Doshi,3 O. Fadugba,4 M. Lim.2

    1Pharmacy Services, Hospital of Univ. of Pennsylvania, Philadelphia, PA; 2Renal Division, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia, PA; 3Temple Univ. School of Pharmacy, Philadelphia, PA; 4Pulmonary Allergy Critical Care Division, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia, PA.

    Background: Tacrolimus (TAC) is considered a drug of choice for maintenance immunosuppression among kidney transplant (KTX) recipients. Because of structural resemblances between macrolide antibiotics (azithromycin,…
  • 2018 American Transplant Congress

    Pre-Transplant Duration of Dialysis, N-Terminal Pro-Brain Natriuretic Peptide and Post-Transplant Mortality in Renal Transplant Recipients

    M. Yeung, M. Van Londen, U. Nakshbandi, Y. Said, M. Eisenga, B. Hepkema, M. Nolte, S. Berger, M. De Borst, S. Bakker.

    Internal Medicine Department, Division Nephrology, University Medical Center Groningen, Groningen, Netherlands.

    Background and objective: Pre-transplant dialysis duration (DD) is associated with increased mortality in renal transplant recipients (RTRs) due to accelerated atherosclerosis, intradialytic volume overload and…
  • 2018 American Transplant Congress

    Parathyroidectomy Outcomes in Renal Transplant Recipients: Subtotal vs. Total

    R. Rathore,1,2 A. Sharma,2 A. Halawa.2

    1Renal Medicine, University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom; 2Faculty of Health, University of Liverpool, Liverpool, United Kingdom.

    Introduction:Best practice in management of persistent hyperparathyroidism in renal transplant recipients has been debated and there is no consensus on whether medical or surgical management…
  • 2018 American Transplant Congress

    The Price of Diabetes Medication Management in Kidney Transplantation: Similar Rates of Readmissions, but More Healthcare Utilization

    J. Hardcopf, H. Meadows, N. Pilch, C. Perez, N. Patel, J. Fleming, H. Corbo, T. Harrison, B. O'Brien, D. DuBay, D. Taber.

    Medical University of South Carolina, Charleston, SC.

    Background: The aim of this study was to determine whether changing diabetes (DM) medications during the index admission for kidney transplant (KT) is significantly associated…
  • 2018 American Transplant Congress

    Factors Influencing Post-Transplant Mortality in Primary Biliary Cholangitis

    V. Mendiratta, K. Alsafadi, D. Venkat.

    Henry Ford Hospital, Detroit.

    Introduction: Primary Biliary Cholangitis (PBC) is a significant cause of end stage liver disease and hepatocellular carcinoma necessitating liver transplant. Little data exists on the…
  • 2018 American Transplant Congress

    Cold Ischemia Time is an Important Risk Factor for Post-Liver Transplant Prolonged Length of Stay

    E. Pan, D. Yoeli, N. Galvan, M. Kueht, R. Cotton, C. O'Mahony, J. Goss, A. Rana.

    Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX.

    Background: Cold ischemia time (CIT) is often viewed as a categorical risk factor in liver transplantation. We hypothesize that the risk for adverse outcomes increases…
  • 2018 American Transplant Congress

    Offer Acceptance Practices and Geographic Variability in Allocation MELD at Transplant

    A. Wey,1 S. Gentry,2 J. Pyke,1 D. Schladt,1 T. Weaver,1 N. Salkowski,1 B. Kasiske,1 A. Israni,1 J. Snyder.1

    1SRTR, Minneapolis; 2U.S. Navy, Anapolis.

    Offer acceptance practices may cause geographic variability in allocation model for end-stage liver disease (aMELD) score at transplant and could magnify the apparent impact of…
  • « Previous Page
  • 1
  • …
  • 194
  • 195
  • 196
  • 197
  • 198
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences